Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -5.30% is 1490% below its 5-year average of -0.33%, near the low end of its 5-year range (-14.67%–26.24%).
As of the fiscal period ended Tuesday, September 30, 2025. 41.57% above its 12-month average of -9.07%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-03-31): -2.18%.
RETURN ON ASSETS (ROA)
-5.30%
RETURN ON ASSETS (ROA) AVG TTM
-9.07%
RETURN ON ASSETS (ROA) AVG 3Y
-11.09%
RETURN ON ASSETS (ROA) AVG 5Y
-0.33%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+41.57%
CURRENT VS 3Y AVG
+52.23%
CURRENT VS 5Y AVG
-1490.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+83.57%
vs the sector median at left
Universe Pharmaceuticals Inc.
Market Cap
$2.66M
Return on Assets (ROA)
-5.30%
TTM Avg
-9.07%
3Y Avg
-11.09%
5Y Avg
-0.33%
Market Cap
$2.69M
Return on Assets (ROA)
-154.47%
TTM Avg
-121.84%
3Y Avg
-88.87%
5Y Avg
-75.91%
Market Cap
$2.56M
Return on Assets (ROA)
-121.85%
TTM Avg
-199.78%
3Y Avg
-166.32%
5Y Avg
-134.78%
Market Cap
$2.54M
Return on Assets (ROA)
-199.30%
TTM Avg
-137.41%
3Y Avg
-109.57%
5Y Avg
-977.62%
Market Cap
$2.86M
Return on Assets (ROA)
-95.33%
TTM Avg
-115.11%
3Y Avg
-93.94%
5Y Avg
-73.81%
Market Cap
$2.44M
Return on Assets (ROA)
-107.18%
TTM Avg
-105.74%
3Y Avg
-98.21%
5Y Avg
-95.08%
Market Cap
$2.94M
Return on Assets (ROA)
-86.02%
TTM Avg
-152.03%
3Y Avg
-125.45%
5Y Avg
-181.83%
Market Cap
$2.38M
Return on Assets (ROA)
-143.82%
TTM Avg
-140.13%
3Y Avg
-102.17%
5Y Avg
-81.19%
Market Cap
$2.38M
Return on Assets (ROA)
-44.98%
TTM Avg
-238.38%
3Y Avg
-161.31%
5Y Avg
-161.69%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Universe Pharmaceuticals Inc. (UPC) | $2.66M | -5.30% | -9.07% | -11.09% | -0.33% |
| iSpecimen Inc. (ISPC)vs › | $2.69M | -154.47% | -121.84% | -88.87% | -75.91% |
| Nuwellis, Inc. (NUWE)vs › | $2.56M | -121.85% | -199.78% | -166.32% | -134.78% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | -199.30% | -137.41% | -109.57% | -977.62% |
| IceCure Medical Ltd (ICCM)vs › | $2.86M | -95.33% | -115.11% | -93.94% | -73.81% |
| Jaguar Health, Inc. (JAGX)vs › | $2.44M | -107.18% | -105.74% | -98.21% | -95.08% |
| Revelation Biosciences, Inc. (REVB)vs › | $2.94M | -86.02% | -152.03% | -125.45% | -181.83% |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.38M | -143.82% | -140.13% | -102.17% | -81.19% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.38M | -44.98% | -238.38% | -161.31% | -161.69% |
| Onconetix, Inc. (ONCO)vs › | $2.37M | -62.07% | -132.28% | -89.58% | -83.72% |
ROA
-5.3%
ROE
-6.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-09-30 | -5.30% |
| 2024-09-30 | -12.84% |
| 2023-09-30 | -11.57% |
| 2022-09-30 | -14.67% |
| 2021-09-30 | 16.14% |
| 2020-09-30 | 26.24% |
| 2019-09-30 | 42.34% |
| 2018-09-30 | 27.08% |
